We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8304:TSEAozora Bank, Ltd. Analysis

Data as of 2026-03-15 - not real-time

¥2,488.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Aozora Bank is trading at ¥2,488, comfortably above its 200‑day SMA of ¥2,355 but below the 20‑day and 50‑day SMAs of ¥2,694 and ¥2,637, indicating a short‑term pull‑back within a longer‑term uptrend. The RSI of 39 suggests the stock is approaching oversold territory, while the MACD histogram remains negative and the signal line is bearish, creating mixed technical signals. Valuation metrics are attractive: a forward P/E of 13.4 and a trailing P/E of 15.65 sit below the industry average of 16.35, and the price‑to‑book ratio of 0.73 is well under 1, implying a discount to net assets. The dividend yield of 3.54% with a payout ratio around 53% adds income appeal, and the company’s revenue surged 25.3% year‑over‑year, supporting a growth narrative. Balance‑sheet strength is evident from ¥1.99 trillion in cash versus ¥1.33 trillion of debt, and the low beta (≈0.06) points to limited market volatility, though the 30‑day price volatility of 42% signals short‑term price swings. Overall, the stock appears undervalued with solid dividend sustainability, but sector‑specific headwinds and modest profitability metrics temper enthusiasm.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support level of ¥2,443
  • Bearish MACD signal
  • RSI indicating potential oversold condition

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued valuation ratios (P/E below industry, P/B < 1)
  • Strong dividend yield and sustainable payout
  • Robust revenue growth of 25.3%

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Low beta and solid cash position reducing market risk
  • Sustainable dividend income
  • Regional banking sector headwinds limiting upside

Key Metrics & Analysis

Financial Health

Revenue Growth25.30%
Profit Margin21.37%
P/E Ratio15.6
ROE5.57%
ROA0.32%
P/B Ratio0.7
Industry P/E16.4

Technical Analysis

TrendBullish
RSI39.2
Support¥2,443.00
Resistance¥2,891.50
MA 20¥2,694.05
MA 50¥2,637.43
MA 200¥2,355.80
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

Target Price¥2,400.00
Upside/Downside-3.54%
GradeUndervalued
TypeBlend
Dividend Yield3.54%

Risk Assessment

Beta0.63
Volatility42.12%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.